Metraipolis › archive › dc_32119e08a173

Cancer vaccines: advances, hurdles, and future directions — Europe PMC PMID:41322103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41322103
DOI
10.37349/etat.2025.1002350
License (as archived)
solo-consultazione
Archived
2026-11-08T07:16:24.225Z
SHA-256 of the archived text
f3bc06af906ed14deef21abebeeb3b71fea733458751191256ab76cf283e886c
Stable URL of this page
https://metraipolis.com/documento/dc_32119e08a173

How to cite

Cancer vaccines: advances, hurdles, and future directions — Europe PMC PMID:41322103 — Europe PMC (en), https://europepmc.org/article/MED/41322103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32119e08a173 (Metraipolis archive dc_32119e08a173, sha256 f3bc06af906ed14deef21abebeeb3b71fea733458751191256ab76cf283e886c)
BibTeX
@misc{dc32119e08a173,
  title = {Cancer vaccines: advances, hurdles, and future directions — Europe PMC PMID:41322103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32119e08a173; sha256 f3bc06af906ed14deef21abebeeb3b71fea733458751191256ab76cf283e886c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322103. Agents can read the archived copy with the MCP tool read_document.